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CHAPTER 7
PREDICTORS OF NON-PHARMACOLOGICAL INTERVENTION IN 
PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: 
VALUE OF NEUROTICISM
Hemels ME, Van den Berg MP, Ranchor AV, Van Sonderen EL, 
Van Gelder IC, Van Veldhuisen DJ





Non-pharmacological intervention is gaining increasing popularity in the treatment of 
patients with paroxysmal atrial fi brillation. We sought to investigate which factors play a role 
in the choice for non-pharmacological intervention with a particular focus on neuroticism. 
Methods
Th e study group comprised 73 patients with paroxysmal atrial fi brillation (mean age 55±13 
years, 50 males). On average, patients had a 3-year-history of one symptomatic paroxysm per 
week lasting 2 hours. Th e degree of neuroticism was assessed using the short scale Eysenck 
Personality Questionnaire. 
Results
During a mean follow-up period of 7.0 ± 0.6 years, 20 patients (27%) underwent a non-
pharmacological intervention for atrial fi brillation including His bundle ablation (n=1), maze 
operation (n=4), DDDR-pacemaker (n=10), pulmonary vein ablation (n=5). Multivariate 
regression analysis showed that age <55 years (odds ratio 5.3, 95% CI 1.1 – 24.5), frequency 
of paroxysms of atrial fi brillation >1 per week (odds ratio 5.9, 95% CI 1.2 – 28.5) and total 
number of anti-arrhythmic drugs (class I and III) used >2 (odds ratio 3.4, 95% CI 1.6 – 6.9) 
were predictive of non-pharmacological intervention (all p<0.05). In contrast, the degree of 
neuroticism was similar in patients who underwent non-pharmacological intervention as 
opposed to patients who did not undergo non-pharmacological intervention (4.5 ± 3.3 vs 4.0 
± 2.9, P=NS). 
Conclusion
Based on the present study, the likelihood of non-pharmacological intervention in patients 
with paroxysmal atrial fi brillation does not seem to be determined by their relative degree 
of neuroticism. Instead, the data indicate that younger patients with pharmacologically 
refractory atrial fi brillation more oft en undergo non-pharmacological intervention. 
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INTRODUCTION
Recent studies have shown that “rate control” is a reasonable alternative for “rhythm 
control” in patients with asymptomatic or mildly symptomatic atrial fi brillation.1,2 However, 
rhythm control is still desirable for highly symptomatic patients. Antiarrhythmic drugs are 
the fi rst line of treatment to achieve rhythm control, but treatment with anti-arrhythmic drugs 
oft en fails, either due to ineff ectiveness or intolerable side eff ects, and non-pharmacological 
intervention should then be considered. In recent years, several non-pharmacological 
treatment modalities have been developed, including His bundle ablation, Cox’s maze 
operation, pacemaker therapy and (modifi ed) pulmonary vein ablation. In particular the 
latter option is gaining increasing popularity,3 both given its alleged eff ectiveness and because 
it leaves open the other treatment options. However, the critical issue in terms of selection 
of a patient for non-pharmacological treatment is how to defi ne what actually constitutes 
“highly symptomatic”.  Obviously, “objective” arrhythmia burden (duration of atrial 
fi brillation, duration and frequency of attacks) and perhaps demographics would appear 
important, but we reasoned that psychological factors might also be implicated in the choice 
for non-pharmacological treatment. In particular, we wondered whether neuroticism plays 
a role. Neuroticism is a steady personality trait, which gives an indication of the emotional 
stability of a person.4 Persons with high scores on neuroticism scales tend to be anxious and 
to have more worries in general, and neuroticism has proved to be an important predictor of 
psychological distress, both in the presence and the absence of stressful circumstances. We felt 
it would be conceivable that neuroticism aff ects the complex interaction between the patient 
and the treating physician such that patients with atrial fi brillation and relatively high degree 
of neuroticism more readily receive non-pharmacological treatment. In the present study, we 
investigated the predictors of non-pharmacological intervention, including the potential role 
of neuroticism, in a well-defi ned group of patients with paroxysmal atrial fi brillation.
 
MATERIALS AND METHODS 
Patient selection and study design
Th e study group consisted of patients who participated in a previous study, which focussed 
on quality of life.5 Briefl y, consecutive patients from the out-patient clinic in our hospital 
with paroxysmal atrial fi brillation, aged >18 years, were considered eligible for the study. 
Paroxysmal atrial fi brillation was defi ned as proposed by Gallagher and Camm.6 Th e 
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presence of atrial fi brillation was based on electrocardiographic evidence, including 
ambulatory (Holter) monitoring. Lone atrial fi brillation was inferred when routine cardiac 
investigations (echocardiogram, ergometry) did not reveal structural heart disease. Patients 
with hypertension were considered to have structural heart disease. In the main study,5 a set of 
questionnaires was distributed between the patients, including a questionnaire on personality, 
that is, neuroticism. Of note, neither the patient or the treating physician (MPVdB, ICVG) were 
informed about the neuroticism score. Aft er the baseline measurements, patients were only 
followed by their treating physician. Subsequent treatment, including non-pharmacological 
intervention, was left  at the discretion of this physician. (see below).  At the end of follow-up 
in January 2004, clinical outcome in terms of non-pharmacological intervention was extracted 
from the patient records by one of the investigators (MEWH). Th e study was performed in 
accordance with Declaration of Helsinki and approved by the institutional ethics committee. 
Informed consent was obtained from all patients.
Neuroticism
Neuroticism was assessed using the revised, short scale Eysenck Personality 
Questionnaire, validated for Dutch (Appendix).7,8 Using this questionnaire, neuroticism is 
quantifi ed using a set of 12 questions, to be answered with yes or no. Possible total score thus 
ranges from 0 to 12, a higher score signifying a higher degree of neuroticism. 
Non-pharmacological intervention
Patients who were selected for a non-pharmacological intervention for the treatment 
of atrial fi brillation were required to be “highly symptomatic”, as judged by the treating 
physician (MPVdB, ICVG).  Several techniques have been applied in recent years in our center, 
refl ecting their rapid evolution and the reported and perceived advantages and disadvantages. 
Initially, His bundle ablation with VVI-pacemaker implantation and maze operation were 
performed relatively frequently, later DDDR pacemaker implantation (antitachy-pacing) and 
particularly pulmonary vein ablation became more popular. With exception of His bundle 
ablation, potential candidates for a non-pharmacological intervention were required to have 
limited or no structural heart disease. 
Data Analysis
Mean values ± the standard deviation and median values with range, depending on 
the normality of the distribution, were calculated for continuous variables and counts with 
percentages for categorical variables. Diff erences between groups were evaluated by the 
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Student t-test or Mann-Whitney U-test, depending on the normality of the distribution, for 
continuous variables and by the Fisher exact test or Chi-square test for categorical variables.
In order to determine predictors of non-pharmacological intervention univariate and 
multivariate logistic regression analyses were performed. All univariate variables with a p-
value <0.10 were added to the multivariate model. Cut-off  points of the variables of interest 
were chosen on basis of the mean or median value. Since we were particularly interested in 
neuroticism, neuroticism-score was forced into the multivariate model. A value of p<0.05 
was considered statistically signifi cant. Analyses were performed using the statistical package 
SPSS 11.0 (SPSS Inc, Chicago, IL, USA).
RESULTS
Patient characteristics
Study patients were recruited between November 1996 and May 1998 and comprised 73 
subjects. Mean age was 55 ± 13 years and 50 patients (68%) were male (Table 1). Lone atrial 
fi brillation was present in 43 patients (59%), the remaining patients suff ered from ischemic 
heart disease (n=12), valvular heart disease (n=7) or hypertension (n=11). None of the 
patients had congestive heart failure. Mean echo-parameters (left  ventricular and left  atrial 
dimensions) were within the normal range. Self-reported arrhythmia burden in terms of the 
duration of the paroxysms ranged from 15 minutes to 2 days, whereas the frequency ranged 
from 2 paroxysms per year to 5 paroxysms per week. On average, patients had a 3-year-history 
of one paroxysm per week lasting 2 hours. Fift y-one patients (70%) used an antiarrhythmic 
drug to suppress their arrhythmia, whereas the remaining 22 patients (30%) used either no 
medication or only medication for control of ventricular rate during AF. Th e median total 
number of used antiarrhythmic drugs (class I and III) was 2 (1-6). All patients fully completed 
and returned the Eysenck Personality Questionnaires.
Non-pharmacological intervention and its predictors
         Follow-up was completed in all patients. Mean follow-up was 7.0 ± 0.6 years. During 
the follow-up period, 20 patients (27%) underwent a non-pharmacological intervention; in 
1 patient a His bundle ablation with implantation of a VVI-pacemaker was performed, in 
4 patients maze operation was performed, 10 patients received a DDDR-pacemaker, and 5 
patients underwent pulmonary vein ablation. Of note, in the present patient group maze 
operation and DDDR pacemaker implantation were performed for atrial fi brillation only (no 
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associated valve or coronary surgery, no conventional pacemaker indication, i.e. antibrady-
pacing). Clinical characteristics of the patients who underwent a non-pharmacological 
intervention as compared to those who treated pharmacologically are shown in Table 1. Th e 
total duration of the atrial fi brillation was longer and the total number of anti-arrhythmic 
drugs used was higher in the patients who underwent an intervention, otherwise there 
were no signifi cant diff erences. Of note, neuroticism score was comparable in the 2 groups; 
Eysenck Personality Questionnaire scores in the non-intervention group and intervention 
group were 4.0 ± 2.9 and 4.5 ± 3.3, respectively (P=NS). Th e results of the univariate and 
multivariate regression analyses are shown in Table 2. In the fi nal model, 3 variables remained 
as independent predictors of non-pharmacological intervention: age <55 years, frequency of 
paroxysms of AF >1 per week and total number of class I and III anti-arrhythmic drugs used 
>2. Th e degree of neuroticism had no predictive value.
Table 1. Clinical characteristics of patients with or without non-pharmacological intervention.
   Intervention  No intervention  p
   (n=20)   (n=53)
Age   52 ± 10   57 ± 14   NS
<55 years (%)  13 (65)   22 (42)   NS
≥55 years (%)  7 (35)   31 (58)   NS
Sex
Male (%)   17 (85)   33 (62)   NS
Female (%)  3 (15)   20 (38)   NS
Underlying heart disease
Ischemic (%)  2 (10)   10 (19)   NS
Valvular (%)  4 (20)   3 (6)   NS
Hypertension (%)  3 (15)   8 (15)   NS
Lone AF (%)  11 (55)   32 (60)   NS
Arrhythmia burden
Total duration (years)  7.0 (1.0-30.0)  2.0 (0.2-24.0)  0.040
Frequency (per week)  1.0 (0.04-5.0)  0.5 (0.04-5.0)  NS
Duration (hours)  6.0 (0.2-48.0)  2.0 (0.3-24.0)  NS
Echo parameters
LA dimension, 
parasternal (mm)    37 ±  6   34 ±  6   NS
LA dimension, 
apical (mm)  53 ±  5   54 ±  8   NS
LVEDD (mm)  46 ±  6   47 ±  5   NS
LVESD (mm)  32 ±  4   32 ±  7   NS
Fractional shortening  0.31 ±  0.07  0.33 ±  0.10  NS
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Medication use (%)
Class I AAD  9 (45)   18 (34)   NS
Class III AAD  11 (55)   13 (25)   NS
β-blockers   8 (40)   17 (32)   NS
Calcium-channel blockers 6 (30)   8 (15)   NS
Digoxin   3 (15)   4 (8)   NS
Number of AADs used 3 (1-6)   2 (0-5)              <0.001
Neuroticism score   4.5 ±  3.3   4.0 ±  2.9   NS
AF = atrial fi brillation, AAD = antiarrhythmic drug, LA = left  atrium, LVEDD = left  ventricular enddiastolic dimension, 
LVESD = left  ventricular endsystolic dimension, NS = not signifi cant
Table 2. Predictors of non-pharmacological intervention. 
   Univariate analysis*   Multivariate analysis
   OR 95% CI p  OR 95% CI p
Age <55 years  2.6 0.9 – 7.6 0.078  5.3 1.1 – 24.5 0.034
Male sex   3.4 0.9 – 13.2 0.073
Valvular heart disease  4.2 0.8 – 20.6 0.08
Total duration >3 years 7.1 2.1 – 25.0 0.002
Frequency >1 per week 1.6 1.0 – 2.5 0.059  5.9 1.2 – 28.5 0.028
Duration >2 hours  3.0 1.0 – 9.1 0.046
Number of AADs used >2 3.0 1.7 – 5.6 <0.001  3.4 1.6 – 6.9 0.001
Neuroticism score >4  1.9 0.7 – 5.5 0.21  1.6 0.4 – 6.6 0.50
AAD = antiarrhythmic drug, OR = odds ratio, CI = confi dence interval. 
*Only variables with a univariate p-value <0.1 and the variable of interest are shown.
DISCUSSION
Atrial fi brillation and psychological factors
Th e role of psychological factors in patients with coronary artery disease is an issue 
of ongoing debate.9,10 A recent study confi rmed that depression and anxiety were associated 
with cardiac events.11 In fact, anxiety was an independent predictor of both cardiac events and 
increased health care consumption and accounted for the relationship between depressive 
symptoms and prognosis. However, studies regarding psychological factors and atrial 
fi brillation are scarce. Using the Barsky Somatosensory Amplifi cation Scale, Paquette and 
coworkers investigated the tendency of atrial fi brillation patients to somatize, i.e. to amplify 
benign bodily sensations, and they showed that a high tendency to somatize predicted a poor 
quality of life.12 Eaker and co-workers recently reported an association between anger and 
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hostility, but not type A behavior, and the development of atrial fi brillation.13 Finally, we 
recently investigated the degree of neuroticism in patients with paroxysmal atrial fi brillation,14 
using the same patient group as in the present study. Perhaps based on clinical experience 
with individual patients one might intuitively surmise that patients with paroxysmal atrial 
fi brillation have on average a higher degree of neuroticism than other persons. However, 
the results clearly indicated that this is not the case; although the Eysenck Personality 
Questionnaire scores on neuroticism diff ered among the individual patients, mean score in 
the group as a whole was similar to the mean score in group of age and sex matched controls 
(4.1 ± 3.0 vs 3.9 ± 3.1, P=NS). In other words, patients with paroxysmal atrial fi brillation 
would appear to have on average a “normal” degree of neuroticism. 
Prediction of non-pharmacological intervention
Notwithstanding the latter observation, we reasoned it would be conceivable that the 
degree of neuroticism plays a role in the choice to perform a non-pharmacological intervention, 
patients with a relatively high degree of neuroticism more readily asking for such treatment 
than patients with a relatively low degree of neuroticism. In addition, the presentation of 
symptoms by the patient might also be coloured by a certain measure of neuroticism such 
that the attending physician believes the patient is highly symptomatic. In the present study, 
several factors were shown to be predictive of a non-pharmacological intervention, namely a 
relatively young age, high frequency of paroxysms of atrial fi brillation and high total number 
of anti-arrhythmic drugs (class I and III) used. Th e predictive value of latter two factors is 
readily conceivable, since they refl ect that the patient suff ers from a pharmacologically 
refractory arrhythmia. Also the fi nding that age plays a role is conceivable, since perhaps both 
the patient and the treating physician more readily feel that “aggressive” treatment is warranted 
in case of (relatively) young age. However, contrary to our supposition, a relatively high 
degree of neuroticism did not turn out to be a predictor of non-pharmacological intervention. 
Putting it diff erently, the decision to perform a non-pharmacological intervention appears to 
be governed by “objective” factors (arrhythmia burden, age), whereas neuroticism does not 
seem to impact the judgment by the treating physician that his/her patient with paroxysmal 
atrial fi brillation is highly symptomatic.  As an explanation for the present fi nding, one might 
argue that patients with a relatively high degree of neuroticism are perhaps also more fearful 
to undergo a non-pharmacological intervention once proposed by their treating physician, 
but this remains sheer speculation.  
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Methodological considerations
An important limitation is that this was a longitudinal retrospective, uncontrolled trial 
and the fact that the sample size was small. As a result, we possibly missed diff erences between 
the groups and were unable to diff erentiate between diff erent types of non-pharmacological 
interventions. For instance, it is not impossible that diff erences exist between catheter-based 
interventions versus operative interventions regarding the role of neuroticism. Further, since 
our institute is a university referral center and we see many patients for a second opinion, 
the patient group may not be entirely representative of clinical practice. Th is possibility is 
supported by the relatively high number of patients with lone atrial fi brillation (59%). 
However, if anything, one would expect neuroticism to play a role in these patients rather 
than in patients in a primary care setting.  Finally, this study was not designed to determine 
whether the patients were “neurotic” in terms of a psychiatric disorder. Instead, the concept of 
neuroticism was used to describe a variant of human personality, and to investigate whether 
the relative degree of neuroticism is predictive of non-pharmacological intervention.
Conclusion
On the basis of this small study, neuroticism would not appear to play an important role 
in the decision to perform a non-pharmacological intervention. Instead, the data indicate 





Eysenck Personality Questionnaire (revised, short scale)
Questions on neuroticism:
1.     Does your mood oft en go up and down? Yes No
2.     Do you ever feel ‘just miserable’ for no reason? Yes No
3.     Are you an irritable person? Yes No
4.     Are your feelings easily hurt? Yes No
5.     Do you oft en feel ‘fed-up’? Yes No
6.     Would you call yourself a nervous person? Yes No
7.     Are you a worrier? Yes No
8.     Would you call yourself tense or ‘highly-strung’? Yes No
9.     Do you worry too long aft er an embarrassing experience? Yes No
10.   Do you suff er from ‘nerves’? Yes No
11.   Do you oft en feel lonely? Yes No
12.   Are you oft en troubled about feelings of guilt? Yes No
Yes = 1; No = 0. Total score is calculated by adding the scores on the individual questions.
REFERENCE LIST
(1) Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel 
MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) 
Investigators. A comparison of rate control and rhythm control in patients with atrial fi brillation. N Engl J Med 
2002; 347:1825-33.
(2) Van Gelder IC, Hagens VE, Bosker HA Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans 
AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study 
Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fi brillation. 
N Engl J Med 2002; 347:1834-40. 
(3) Pappone C, Rosiano S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, 
Santinelli V, Tortoriello V, Sala S, Zangrillo A, Crescenzi G, Benussi S, Alfi eri O. Mortality, morbidity, and 
quality of life aft er circumferential pulmonary vein ablation for atrial fi brillation: outcome from a controlled 
nonrandomized long-term study. J Am Coll Cardiol 2003; 42:198-200.
(4) Ranchor AV, Sanderman R, Steptoe A, Wardle J, Miedema I, Ormel J. Pre-morbid predictors of psychological 
adjustment to cancer. Qual Life Res. 2002; 11:101-13. 
(5) Van den Berg MP, Hassink RJ, Tuinenburg AE, Van Sonderen EF, Lefrandt JD, De Kam PJ, Van Gelder IC, Smit 
AJ, Sanderman R, Crijns HJ. Quality of life in patients with atrial fi brillation and its predictors: importance of 
the autonomic nervous system. Eur Heart J 2001; 22:247-53.
(6) Gallagher MM, Camm AJ. Classifi cation of atrial fi brillation. Pacing Clin Electrophysiol 1997; 20:1603-5.
Predictors of Non-Pharmacological Intervention in Patients with Paroxysmal Atrial Fibrillation
181
(7) Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the Psychoticism scale. 
 Personal Individ Diff . 1985; 6:21-9.
(8) Sanderman R, Arrindell WA, Ranchor AV, Eysenck HJ, Eysenck SBG. Th e assessment of personality traits 
with the Eysenck Personality Questionnaire (EPQ): a manual. Groningen: Northern Centre for Health Care 
Publishers 1995.
(9) Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M. Coronary 
 heart disease in the Western Collaborative Group Study. Final follow-up experience of  8½ years. JAMA 1975; 
233:872-7.
(10) Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent 
predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347:417-21.
(11) Strik JJMH, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors 
of cardiac events and increased health care consumption aft er myocardial infarction. J Am Coll Cardiol 2003; 
42:1801-7. 
(12) Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C, Dorian P. Role of gender and personality on 
quality-of-life impairment in intermittent atrial fi brillation. Am J Cardiol 2000; 86:764-8.
(13) Eaker ED, Sullivan LM, Kelly-Hayes M, D’Agostino RB, Benjamin J. Anger and hostility predict the 
development of atrial fi brillation in men in the Framingham Off spring study. Circulation 2004; 109:1267-71.
(14) Van den Berg MP, Ranchor AV, Van Sonderen FLP, Van Gelder IC, Van Veldhuisen 
 DJ. Paroxysmal atrial fi brillation, quality of life and neuroticism. Neth J Med 2005; 63:170-74.
 

